Deferoxamine Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-173

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferoxamine Mesylate (NDC 68083-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image2g (Deferoxamine 2g)

Deferoxamine Mesylate is a prescription drug available for subcutaneous, intramuscular, or intravenous use in single-dose only. After reconstitution, it should be used immediately and should not be used if the solution is turbid. Any unused portion should be discarded. It can be stored at controlled room temperature 20° to 25°C (68° to 77°F). The manufacturer is Gland Pharma Limited in Hyderabad, India. No information is available regarding the varnish area and expiration date.*

FDA Label Image

Deferoxamine01 (Deferoxamine01)

FDA Label Image

Image02 (Deferoxamine02)

Deferoxamine Mesylate is a prescription drug available in the form of an injection used for SC, IM or IV administration. It is manufactured by GLAND PHARMA LIMITED in India and comes in a package of 500 mg per vial. The drug needs to be stored at a temperature of 20°C to 25°C (68°F to 77°F) listed by USP as controlled room temperature. The medicine should be discarded after use and any unused portion should be returned. The package insert contains instructions for use and further details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.